Art
J-GLOBAL ID:201402204809955830   Reference number:14A0578218

SGLT2阻害薬エンパグリフロジン(EMPA)の日本人2型糖尿病患者での薬物動態/薬力学及び安全性に対する腎機能障害の影響

Author (10):
Material:
Volume: 57  Issue: Supplement 1  Page: S.395  Publication year: Apr. 25, 2014 
JST Material Number: Z0279B  ISSN: 0021-437X  Document type: Article
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0578218&from=J-GLOBAL&jstjournalNo=Z0279B") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of drugs acting on carbohydrate metabolism  ,  Treatment for metabolic diseases,nutritional diseases. 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page